Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 309 F0)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Vinflunine (Primary) ; Methotrexate
- Indications Head and neck cancer; Squamous cell cancer
- Focus Registrational; Therapeutic Use
- Sponsors Pierre Fabre
- 17 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2017.
- 17 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2017.
- 17 Feb 2017 Status changed from recruiting to active, no longer recruiting.